Provided by Tiger Trade Technology Pte. Ltd.

Champions Oncology

5.98
+0.03000.50%
Volume:2.14K
Turnover:12.90K
Market Cap:83.04M
PE:34.27
High:6.05
Open:5.99
Low:5.98
Close:5.95
52wk High:11.33
52wk Low:5.59
Shares:13.89M
Float Shares:5.19M
Volume Ratio:0.23
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1745
EPS(LYR):0.3300
ROE:98.94%
ROA:5.56%
PB:19.91
PE(LYR):18.12

Loading ...

Champions Oncology Inc. Files Initial Statement of Beneficial Ownership for Director Robert Lawrence Brainin

Reuters
·
Jan 17

Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improves

Reuters
·
Dec 16, 2025

Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate

Benzinga
·
Dec 16, 2025

BRIEF-Champions Oncology Q2 Adjusted EPS USD 0.06

Reuters
·
Dec 16, 2025

Champions Oncology Q2 service revenue rises 11% to USD 15 million

Reuters
·
Dec 16, 2025

Craig-Hallum Sticks to Their Buy Rating for Champions Oncology (CSBR)

TIPRANKS
·
Oct 24, 2025

Champions Oncology Holds Annual Stockholders Meeting

TIPRANKS
·
Oct 17, 2025

Champions Oncology Earnings Call: Cautious Optimism Amid Challenges

TIPRANKS
·
Sep 18, 2025

Craig-Hallum Remains a Buy on Champions Oncology (CSBR)

TIPRANKS
·
Sep 16, 2025

The Market Lifts Champions Oncology, Inc. (NASDAQ:CSBR) Shares 27% But It Can Do More

Simply Wall St.
·
Sep 16, 2025

Champions Oncology Reports Steady Revenue and New Leadership

TIPRANKS
·
Sep 16, 2025

Champions Oncology Q1 Adjusted EPS USD 0.02

Reuters
·
Sep 16, 2025

Champions Oncology Reports $14 Million Revenue for Q1 FY 2026, Adjusted EBITDA at $60,000; Revenue Slightly Lower Than Last Year

Reuters
·
Sep 16, 2025

Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
Sep 13, 2025

Craig-Hallum Reaffirms Their Buy Rating on Champions Oncology (CSBR)

TIPRANKS
·
Sep 12, 2025

Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
Sep 05, 2025

Champions Oncology Inc. Announces Date for Annual Stockholders Meeting

Reuters
·
Aug 23, 2025

Champions Oncology Q4 Adj. EPS $(0.07) Beats $(0.20) Estimate, Sales $12.355M Beat $12.013M Estimate

Benzinga
·
Jul 24, 2025

Champions Oncology Reports Record $57M Annual Revenue, Net Income of $4.6M, and 14% Growth in Fiscal 2025

Reuters
·
Jul 24, 2025

Champions Oncology Q4 Adjusted Ebitda USD -1.016 Million

THOMSON REUTERS
·
Jul 24, 2025